(VIANEWS) – Li Auto (LI), New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share (EDU), Xylem (XYL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Li Auto (LI)
65% sales growth and 22.33% return on equity
Li Auto Inc., through its subsidiaries, operates in the energy vehicle market in the People's Republic of China. It designs, develops, manufactures, and sells premium smart electric vehicles. The company's product line comprises MPVs and sport utility vehicles. It also offers sales and after sales management, and technology development and corporate management services, as well as purchases manufacturing equipment. The company offers its products through online and offline channels. The company was formerly known as Leading Ideal Inc. and changed its name to Li Auto Inc. in July 2020. Li Auto Inc. was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Earnings Per Share
As for profitability, Li Auto has a trailing twelve months EPS of $1.54.
PE Ratio
Li Auto has a trailing twelve months price to earnings ratio of 20.03. Meaning, the purchaser of the share is investing $20.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.33%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Li Auto’s EBITDA is 9.09.
2. New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share (EDU)
27.9% sales growth and 8.8% return on equity
New Oriental Education & Technology Group Inc. provides private educational services under the New Oriental brand in the People's Republic of China. It operates through K-12 AST, Test Preparation and Other Courses; and Others segments. The company offers test preparation courses to students taking language and entrance exams used by educational institutions in the United States, the People's Republic of China, and the Commonwealth countries; and after-school tutoring courses for middle and high school students to enhance their exam scores, as well as for children to teach English. It also provides language training courses, including English, as well as other foreign languages, such as German, Japanese, French, Korean, Italian, and Spanish; operates a full-time private primary and secondary school in Yangzhou seeking a full curriculum with a focus on English; develops and edits educational materials for language training and test preparation; and offers online education programs that include college, K-12, and pre-school education. In addition, the company offers overseas studies consulting and overseas study tour services. As of May 31, 2020, it offered educational programs, services, and products to students through a network of 104 schools, 1,361 learning centers, and 12 bookstores. The company was founded in 1993 and is headquartered in Beijing, the People's Republic of China.
Earnings Per Share
As for profitability, New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share has a trailing twelve months EPS of $1.8.
PE Ratio
New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share has a trailing twelve months price to earnings ratio of 48.58. Meaning, the purchaser of the share is investing $48.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share’s EBITDA is 455.64.
Yearly Top and Bottom Value
New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share’s stock is valued at $87.44 at 06:22 EST, way below its 52-week high of $98.20 and way above its 52-week low of $35.70.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1216.7% and 70.3%, respectively.
3. Xylem (XYL)
22.3% sales growth and 8.9% return on equity
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Xylem Vue, and Flojet brands. The Measurement & Control Solutions segment offers smart meters, networked communication devices, data analytics, test equipment, controls, sensor devices, software and managed services, and critical infrastructure services; and software and services, including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management, and pressure monitoring solutions, as well as testing equipment. This segment sells its products under the Pure Technologies, Sensus, Smith Blair, WTW, Xylem Vue, and YSI brands. The Integrated Solutions and Services segment provides maintenance services, mobile services, digital outsourced solutions, wastewater systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, ion exchange, and deionization under Aquapro, WaterOne, and Ion Pure brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in May 2011. Xylem Inc. was incorporated in 2011 and is headquartered in Washington, District of Columbia.
Earnings Per Share
As for profitability, Xylem has a trailing twelve months EPS of $2.79.
PE Ratio
Xylem has a trailing twelve months price to earnings ratio of 46.16. Meaning, the purchaser of the share is investing $46.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.9%.
Volume
Today’s last reported volume for Xylem is 704323 which is 39.49% below its average volume of 1163990.
4. Lantheus Holdings (LNTH)
16.4% sales growth and 51.73% return on equity
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.
Earnings Per Share
As for profitability, Lantheus Holdings has a trailing twelve months EPS of $4.65.
PE Ratio
Lantheus Holdings has a trailing twelve months price to earnings ratio of 13.38. Meaning, the purchaser of the share is investing $13.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 51.73%.
Sales Growth
Lantheus Holdings’s sales growth is 15.7% for the current quarter and 16.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Lantheus Holdings’s EBITDA is 26.81.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.5%, now sitting on 1.3B for the twelve trailing months.
Previous days news about Lantheus Holdings(LNTH)
- Lantheus holdings (lnth) beats stock market upswing: what investors need to know. According to Zacks on Tuesday, 9 April, "Investors will be eagerly watching for the performance of Lantheus Holdings in its upcoming earnings disclosure. ", "Its industry sports an average Forward P/E of 21.64, so one might conclude that Lantheus Holdings is trading at a discount comparatively."
5. Erie Indemnity Company (ERIE)
11.2% sales growth and 28.67% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $8.51.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 46.08. Meaning, the purchaser of the share is investing $46.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.67%.
Moving Average
Erie Indemnity Company’s value is above its 50-day moving average of $383.56 and way higher than its 200-day moving average of $308.51.
6. Sapiens International Corporation N.V. (SPNS)
7% sales growth and 14.74% return on equity
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Sapiens International Corporation N.V. has a trailing twelve months EPS of $1.12.
PE Ratio
Sapiens International Corporation N.V. has a trailing twelve months price to earnings ratio of 27.46. Meaning, the purchaser of the share is investing $27.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.74%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sapiens International Corporation N.V.’s EBITDA is 58.37.
Volume
Today’s last reported volume for Sapiens International Corporation N.V. is 86489 which is 18.79% below its average volume of 106506.
7. Pro-Dex (PDEX)
6.2% sales growth and 10.68% return on equity
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Pro-Dex has a trailing twelve months EPS of $0.84.
PE Ratio
Pro-Dex has a trailing twelve months price to earnings ratio of 20.41. Meaning, the purchaser of the share is investing $20.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.68%.
Sales Growth
Pro-Dex’s sales growth for the next quarter is 6.2%.
Volume
Today’s last reported volume for Pro-Dex is 3109 which is 63.22% below its average volume of 8455.
Moving Average
Pro-Dex’s value is below its 50-day moving average of $18.95 and below its 200-day moving average of $17.73.
8. Telefonica Brasil, S.A. ADS (VIV)
5.5% sales growth and 7.3% return on equity
Telefônica Brasil S.A., together with its subsidiaries, operates as a mobile telecommunications company in Brazil. Its fixed line services portfolio includes local, domestic long-distance, and international long-distance calls; and mobile portfolio comprises voice and broadband internet access through 3G, 4G, 4.5G, and 5G, as well as mobile value-added and wireless roaming services. The company also offers data services, including broadband and mobile data services. In addition, it provides pay TV services through IPTV technologies; network services, such as rental of facilities; other services comprising internet access, private network connectivity, computer equipment leasing, extended service, caller identification, voice mail, cellular blocker, and others; wholesale services, including interconnection services to users of other network providers; and digital services, such as entertainment, cloud, and security and financial services. Further, the company offers multimedia communication services, which include audio, data, voice and other sounds, images, texts, and other information, as well as sells devices, such as smartphones, broadband USB modems, and other devices. Additionally, it provides telecommunications solutions and IT support to various industries, such as retail, manufacturing, services, financial institutions, government, etc. It markets and sells its solutions through own stores, dealers, retail and distribution channels, door-to-door sales, and outbound tele sales. The company was formerly known as Telecomunicações de São Paulo S.A. – TELESP and changed its name to Telefônica Brasil S.A. in October 2011. The company was incorporated in 1998 and is headquartered in São Paulo, Brazil.
Earnings Per Share
As for profitability, Telefonica Brasil, S.A. ADS has a trailing twelve months EPS of $0.61.
PE Ratio
Telefonica Brasil, S.A. ADS has a trailing twelve months price to earnings ratio of 16.7. Meaning, the purchaser of the share is investing $16.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.3%.
